Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MZI | Ann: Sale of Keysbrook Leucoxene Pty Ltd | 01/07/21 | 25 | 18K | |||
|
|||||||
MZI | Ann: Removal from Official List | 01/05/20 | 0 | 1.1K | |||
|
|||||||
MZI | Ann: Execution of Deed of Company Arrangement | 10/03/20 | 0 | 944 | |||
|
|||||||
MZI | News: MZI Mcgrathnicol Updates On Sale Campaign For MZI Resources Listed Corporate Shell | 09/12/19 | 0 | 1.0K | |||
|
|||||||
MZI | Ann: Update from Administrators | 09/12/19 | 0 | 1.1K | |||
|
|||||||
MZI | Ann: ASIC Reporting Relief | 12:11 | 0 | 735 | |||
|
|||||||
MZI | Ann: Change of Company Officeholders | 15/10/19 | 0 | 1.6K | |||
|
|||||||
MZI | Ann: Suspension from Official Quotation - Annual Listing Fee | 22/08/19 | 0 | 725 | |||
|
See All Discussions